Your browser doesn't support javascript.
Effectiveness of National Residential Smoking Cessation Program.
Park, Mi-Jeong; Seo, Young-Gyun; Noh, Hye-Mi; Kim, Yeol; Yoon, Jong Lull; Paek, Yu-Jin.
  • Park MJ; Department of Family Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong 18450, Korea.
  • Seo YG; Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Korea.
  • Noh HM; Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Korea.
  • Kim Y; National Cancer Center, Division of Center for Cancer Prevention and Detection, Goyang 10408, Korea.
  • Yoon JL; National Cancer Center, National Cancer Control Institute, Goyang 10408, Korea.
  • Paek YJ; Department of Family Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong 18450, Korea.
Int J Environ Res Public Health ; 18(18)2021 09 20.
Article in English | MEDLINE | ID: covidwho-1438582
ABSTRACT
We aimed to investigate the effectiveness of the Korean national five-day residential smoking cessation program and the factors affecting the long-term smoking cessation of participants. The residential smoking cessation program (2017-2018) recruited smokers with a smoking duration ≥ 20 years and who have attempted to quit smoking more than twice and/or smokers with chronic morbidities. Participants underwent an intensive intervention, including individual psychological therapy, group therapy, medical counseling, and pharmacotherapy. The 6-month continuous abstinence rate (CAR) was assessed via self-reports, the urine cotinine levels, and/or expired-air carbon monoxide levels. Logistic regression was used to analyze the adjusted odds ratio (aOR) to assess factors related to smoking cessation. Overall, 484 participants who completed the residential program and questionnaire were evaluated. The 3- and 6-month CAR were 81.82% and 63.22%, respectively. The aOR of 6-month continuous abstinence was lower among participants with severe nicotine dependence (aOR 0.46, 95% confidence interval [CI] 0.26-0.81) and higher among participants with combination therapy of varenicline with short-term nicotine replacement therapy (NRT) (aOR 1.64, 95% CI 1.07-2.51), with higher self-efficacy (aOR 1.97, 95% CI 1.15-3.37). The residential smoking cessation program was effective. High self-efficacy, combination therapy of varenicline with short-term NRT, and low nicotine dependence were associated with a high 6-month CAR.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tobacco Use Disorder / Smoking Cessation Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tobacco Use Disorder / Smoking Cessation Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article